Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Pariente

Showing results (131-140 of 220) with videos related to

Pageof 22
Sort By:
BMJ (Clinical Research Ed.)|June 9, 2016
Authors' reply to Tufan and colleagues and Boucaud-MaitreFrancesco Salvo, Nicholas Moore, Mickael Arnaud, et al.
British Journal of Clinical Pharmacology|January 17, 2018
Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactionsThomas Deljehier, Antoine Pariente, Ghada Miremont-Salamé, et al.
Global Health Action|March 29, 2018
Non-communicable diseases in Indian slums: re-framing the Social Determinants of HealthLily Beth Lumagbas, Harry Laurence Selby Coleman, Joske Bunders, et al.
Drug Safety|January 25, 2020
Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance DatabaseThomas Berbain, Antoine Pariente, Ghada Miremont-Salamé, et al.
BMJ (Clinical Research Ed.)|May 5, 2016
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysisFrancesco Salvo, Nicholas Moore, Mickael Arnaud, et al.
Journal of General Internal Medicine|June 3, 2024
Contribution of Potentially Inappropriate Medications to Polypharmacy-Associated Risk of Mortality in Middle-Aged Patients: A National Cohort StudyJordan Guillot, Amy C Justice, Kirsha S Gordon, et al.
European Journal of Clinical Pharmacology|March 30, 2016
Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine usersAnne Bénard-Laribière, Pernelle Noize, Elodie Pambrun, et al.
Alzheimer'S Research & Therapy|January 8, 2022
Antiherpetic drugs: a potential way to prevent Alzheimer's disease?Morgane Linard, Julien Bezin, Emilie Hucteau, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2005
[Oncological results of 117 consecutive radical prostatectomies]François-Nicolas Turpin-Wendling, Ahmed Sahnoun, Antoine Pariente, et al.
Pharmacoepidemiology and Drug Safety|November 4, 2016
Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based studyAnne Bénard-Laribière, Pernelle Noize, Elodie Pambrun, et al.
Pageof 22

Showing results (131-140 of 220) with videos related to

Sort By:
Pageof 22
BMJ (Clinical Research Ed.)|June 9, 2016
Authors' reply to Tufan and colleagues and Boucaud-MaitreFrancesco Salvo, Nicholas Moore, Mickael Arnaud, et al.
British Journal of Clinical Pharmacology|January 17, 2018
Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactionsThomas Deljehier, Antoine Pariente, Ghada Miremont-Salamé, et al.
Global Health Action|March 29, 2018
Non-communicable diseases in Indian slums: re-framing the Social Determinants of HealthLily Beth Lumagbas, Harry Laurence Selby Coleman, Joske Bunders, et al.
Drug Safety|January 25, 2020
Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance DatabaseThomas Berbain, Antoine Pariente, Ghada Miremont-Salamé, et al.
BMJ (Clinical Research Ed.)|May 5, 2016
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysisFrancesco Salvo, Nicholas Moore, Mickael Arnaud, et al.
Journal of General Internal Medicine|June 3, 2024
Contribution of Potentially Inappropriate Medications to Polypharmacy-Associated Risk of Mortality in Middle-Aged Patients: A National Cohort StudyJordan Guillot, Amy C Justice, Kirsha S Gordon, et al.
European Journal of Clinical Pharmacology|March 30, 2016
Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine usersAnne Bénard-Laribière, Pernelle Noize, Elodie Pambrun, et al.
Alzheimer'S Research & Therapy|January 8, 2022
Antiherpetic drugs: a potential way to prevent Alzheimer's disease?Morgane Linard, Julien Bezin, Emilie Hucteau, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2005
[Oncological results of 117 consecutive radical prostatectomies]François-Nicolas Turpin-Wendling, Ahmed Sahnoun, Antoine Pariente, et al.
Pharmacoepidemiology and Drug Safety|November 4, 2016
Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based studyAnne Bénard-Laribière, Pernelle Noize, Elodie Pambrun, et al.
Pageof 22